| Challenges in personalized nutrition and health M Verma, R Hontecillas, N Tubau-Juni, V Abedi, J Bassaganya-Riera Frontiers in Nutrition 5, 117, 2018 | 99 | 2018 |
| Abscisic acid: a novel nutraceutical for glycemic control E Zocchi, R Hontecillas, A Leber, A Einerhand, A Carbo, S Bruzzone, ... Frontiers in nutrition 4, 24, 2017 | 81 | 2017 |
| NLRX1 regulates effector and metabolic functions of CD4+ T cells A Leber, R Hontecillas, N Tubau-Juni, V Zoccoli-Rodriguez, M Hulver, ... The Journal of Immunology 198 (6), 2260-2268, 2017 | 63 | 2017 |
| nlrX1 Modulates immunometabolic Mechanisms controlling the host–gut Microbiota interactions during inflammatory Bowel Disease A Leber, R Hontecillas, N Tubau-Juni, V Zoccoli-Rodriguez, V Abedi, ... Frontiers in Immunology 9, 338849, 2018 | 59 | 2018 |
| Modeling new immunoregulatory therapeutics as antimicrobial alternatives for treating Clostridium difficile infection A Leber, R Hontecillas, V Abedi, N Tubau-Juni, V Zoccoli-Rodriguez, ... Artificial intelligence in medicine 78, 1-13, 2017 | 43 | 2017 |
| Modulation of immune signaling and metabolism highlights host and fungal transcriptional responses in mouse models of invasive pulmonary aspergillosis SD Kale, T Ayubi, D Chung, N Tubau-Juni, A Leber, HX Dang, S Karyala, ... Scientific reports 7 (1), 17096, 2017 | 39 | 2017 |
| Modeling-enabled characterization of novel NLRX1 ligands P Lu, R Hontecillas, V Abedi, S Kale, A Leber, C Heltzel, M Langowski, ... PLoS One 10 (12), e0145420, 2015 | 34 | 2015 |
| Modeling-enabled systems nutritional immunology M Verma, R Hontecillas, V Abedi, A Leber, N Tubau-Juni, C Philipson, ... Frontiers in nutrition 3, 5, 2016 | 29 | 2016 |
| Abscisic acid enriched fig extract promotes insulin sensitivity by decreasing systemic inflammation and activating LANCL2 in skeletal muscle A Leber, R Hontecillas, N Tubau-Juni, V Zoccoli-Rodriguez, B Goodpaster, ... Scientific Reports 10 (1), 10463, 2020 | 22 | 2020 |
| Cooperation of gastric mononuclear phagocytes with Helicobacter pylori during colonization M Viladomiu, J Bassaganya-Riera, N Tubau-Juni, B Kronsteiner, A Leber, ... The Journal of Immunology 198 (8), 3195-3204, 2017 | 21 | 2017 |
| Lanthionine synthetase C-like 2 modulates immune responses to influenza virus infection A Leber, J Bassaganya-Riera, N Tubau-Juni, V Zoccoli-Rodriguez, P Lu, ... Frontiers in immunology 8, 178, 2017 | 21 | 2017 |
| Phase III placebo-controlled, randomized clinical trial with synthetic Crohn’s disease patients to evaluate treatment response V Abedi, P Lu, R Hontecillas, M Verma, G Vess, CW Philipson, A Carbo, ... Computational Modeling-Based Discovery of Novel Classes of Anti-Inflammatory …, 2015 | 20 | 2015 |
| NLRX1 is a key regulator of immune signaling during invasive pulmonary aspergillosis B Kastelberg, N Tubau-Juni, T Ayubi, A Leung, A Leber, R Hontecillas, ... PLoS pathogens 16 (9), e1008854, 2020 | 18 | 2020 |
| Computer-aided drug discovery P Lu, DR Bevan, A Leber, R Hontecillas, N Tubau-Juni, ... Accelerated Path to Cures, 7-24, 2018 | 18 | 2018 |
| Modeling the Role of Lanthionine Synthetase C-Like 2 (LANCL2) in the Modulation of Immune Responses to Helicobacter pylori Infection A Leber, J Bassaganya-Riera, N Tubau-Juni, V Zoccoli-Rodriguez, ... PLoS One 11 (12), e0167440, 2016 | 18 | 2016 |
| High-resolution computational modeling of immune responses in the gut M Verma, J Bassaganya-Riera, A Leber, N Tubau-Juni, S Hoops, V Abedi, ... GigaScience 8 (6), giz062, 2019 | 16 | 2019 |
| Development of Synthetic Patient Populations and In Silico Clinical Trials R Zand, V Abedi, R Hontecillas, P Lu, N Noorbakhsh-Sabet, M Verma, ... Accelerated Path to Cures, 57-77, 2018 | 12 | 2018 |
| Identification of new regulatory genes through expression pattern analysis of a global RNA-seq dataset from a Helicobacter pylori co-culture system N Tubau-Juni, J Bassaganya-Riera, A Leber, V Zoccoli-Rodriguez, ... Scientific reports 10 (1), 11506, 2020 | 10 | 2020 |
| Translating nutritional immunology into drug development for inflammatory bowel disease A Leber, R Hontecillas, N Tubau-Juni, J Bassaganya-Riera Current Opinion in Gastroenterology 32 (6), 443-449, 2016 | 10 | 2016 |
| First-in-class topical therapeutic omilancor ameliorates disease severity and inflammation through activation of LANCL2 pathway in psoriasis N Tubau-Juni, R Hontecillas, A Leber, P Maturavongsadit, J Chauhan, ... Scientific Reports 11 (1), 19827, 2021 | 7 | 2021 |
